<DOC>
	<DOCNO>NCT01959685</DOCNO>
	<brief_summary>To determine tolerability pharmacokinetics ( PK ) single dose Androxal healthy adult male subject dose investigate thorough QT interval/corrected QT interval ( QT/QTc ) study .</brief_summary>
	<brief_title>A Dose Escalating Study Determine Tolerability PK Single Dose Androxal</brief_title>
	<detailed_description>A dose escalating study determine tolerability pharmacokinetics ( PK ) supra-therapeutic dose Androxal , 250 mg , healthy adult male subject dose investigate thorough QT interval/corrected QT interval ( QT/QTc ) study .</detailed_description>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<criteria>Speaks , read , understand English Spanish willing able provide write informed consent institutional review board ( IRB ) approve form prior initiation study procedure ; Male , age 1860 year ; No significant abnormal finding screen physical examination evaluate Investigator ; Normal laboratory value ( abnormal clinically significant ) screening determined Investigator ; Subject willing remain clinic overnight Day 1 Day 8 visit ; Must able swallow gelatin capsule Known hypersensitivity Clomid ; Abnormal screen visit vital sign clinical laboratory evaluation consider clinically significant Investigator ; Subject significant organ abnormality disease determine Investigator ; Any medical condition would interfere study determined Investigator ; Slow cytochrome P450 2D6 ( CYP2D6 ) metabolizer Participation clinical trial investigational medication within 30 day prior study medication administration ; An acute illness within 5 day study medication administration ; Positive urine drug screen screen visit ; A mental condition render subject unable understand nature , scope , possible consequence study and/or evidence uncooperative attitude , determine Investigator ; History venous thromboembolic disease ( e.g . deep vein thrombosis pulmonary embolism ) ; History myocardial infarction , unstable angina , symptomatic heart failure , ventricular dysrhythmia , know history QTc interval prolongation ; An employee family member employee study site Sponsor ;</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>